Posted by Adgully Bureau | April 30th, 2010 at 7:45 am
According to the report, the largest swath of the segment, mattresses and pillows, is expected to grow at a CAGR of 3.3%, shooting up to nearly $12.5 billion in 2014.
The second-largest segment, sleep laboratories, was pegged at $6.7 billion in 2009, and is predicted to rise at a 5-year CAGR of 6.5% to touch a mark higher than $9.2 billion in 2014.
The medications segment may overhaul the $7.7 billion mark in 2014, after rising at a CAGR of 8.3% from the 2009 value ($5.2 billion).
Sleep apnea devices, constituting the smallest segment, had a valuation of nearly $2.6 billion in 2009. It is forecast that the segment will rise to nearly $3.8 billion in 2014, fuelled by a CAGR of 7.8%.
The BCC Research report aims to accomplish a comprehensive study of sleep disorders and treatments. The methods used to treat the disorders are discussed in depth, and the market for the ameliorative offerings are analysed.

















